Richard L. Hengel

Cutting Edge: L-Selectin (CD62L) Expression Distinguishes Small Resting Memory CD4+ T Cells That Preferentially Respond to Recall Antigen

Richard L. Hengel, Vishakha Thaker, Mark Pavlick et al. · The Journal of Immunology · 2003 · 121 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

Onyema Ogbuagu, Peter Ruane, Daniel Podzamczer et al. · The Lancet HIV · 2021 · 91 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4+/CD25+ T cells

Irini Sereti, Hector Martinez-Wilson, Julia A. Metcalf et al. · Blood · 2002 · 66 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

CCR5 and CXCR4 Expression on Memory and Naive T Cells in HIV-1 Infection and Response to Highly Active Antiretroviral Therapy

Janet K.A. Nicholson, Sandra W. Browning, Richard L. Hengel et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 53 citations

Life Sciences, Immunology, Infectious Diseases +16

Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy

Joseph A. Kovacs, Susan Vogel, Julia A. Metcalf et al. · European Journal of Immunology · 2001 · 53 citations

Life Sciences, Immunology, Infectious Diseases +17